Research Progress in the Multi-Target Treatment of Dry Eye Disease by Traditional Chinese Medicine Regulating the "Inflammation-Neuro-Metabolism" Interaction Network.
文献摘要
Background Dry eye disease (DED) is a multifactorial, symptomatic disease of the ocular surface microenvironment characterized by loss of homeostasis of the tear film and/or ocular surface. Tear film instability and hyperosmolarity, ocular surface inflammation and damage, neurosensory abnormalities, and metabolic stress interact to sustain disease chronicity. Key mechanisms This review synthesizes current evidence on NLRP3 inflammasome-mediated pyroptosis, NF-κB-related inflammatory signaling, glycolytic and amino-acid metabolic reprogramming, oxidative stress, and the neuro-immune-metabolic axis in DED. Traditional chinese medicine tcm TCM-derived active compounds and formulas act at multiple molecular nodes, including JAK-STAT, NF-κB, NLRP3, MAPK, PI3K/AKT, and Nrf2-related pathways, with reported anti-inflammatory, antioxidant, anti-apoptotic, barrier-protective, metabolic, and neuroprotective effects. Most mechanistic evidence remains preclinical, whereas clinical evidence for TCM formulas is emerging but heterogeneous. Conclusion The available evidence supports a network-oriented framework in which TCM interventions may influence interconnected inflammatory, neural, and metabolic processes rather than a single pathway. Future work should prioritize standardized preparations, mechanism-linked randomized trials, DED subtype stratification, long-term safety, patient-reported outcomes, and multi-omics validation to clarify clinical effectiveness and translational value.